Literature DB >> 16716946

Characterization of transient expression system for retroviral vector production.

Akitsu Hotta1, Yoshikazu Saito, Kenji Kyogoku, Yoshinori Kawabe, Ken-ichi Nishijima, Masamichi Kamihira, Shinji Iijima.   

Abstract

The production of retroviral vectors using a transient expression system has been improved to obtain a high-titer virus preparation that is difficult to produce using packaging cell lines due to the cytotoxic or cytostatic effect of transgenes. Here, we used one such production method, the so-called Q-vector system, and examined its potential for virus production. The Q-vector system could produce a similar level of viral vectors compared with the packaging cell system but the production seemed to depend on the size and nature of transgenes. In the process of investigation of the quantitative difference in viral components between the transient expression system and the packaging cell system, we found that the Q-vector system could express higher amounts of viral RNA and proteins compared with the packaging cell system. However, this did not lead to a higher virus titer compared with that produced by the packaging cell system. This suggests that retroviral RNA transcribed from the plasmid in the transient system seemed to be used mainly for translation and only some of the RNA molecules were packaged in viral particles.

Mesh:

Substances:

Year:  2006        PMID: 16716946     DOI: 10.1263/jbb.101.361

Source DB:  PubMed          Journal:  J Biosci Bioeng        ISSN: 1347-4421            Impact factor:   2.894


  8 in total

1.  Genetic modification of a chicken expression system for the galactosylation of therapeutic proteins produced in egg white.

Authors:  Akifumi Mizutani; Hiroyuki Tsunashima; Ken-ichi Nishijima; Takako Sasamoto; Yuki Yamada; Yasuhiro Kojima; Makoto Motono; Jun Kojima; Yujin Inayoshi; Katsuhide Miyake; Enoch Y Park; Shinji Iijima
Journal:  Transgenic Res       Date:  2011-04-13       Impact factor: 2.788

2.  Transcription factor YY1 interacts with retroviral integrases and facilitates integration of moloney murine leukemia virus cDNA into the host chromosomes.

Authors:  Yujin Inayoshi; Yuuki Okino; Katsuhide Miyake; Akifumi Mizutani; Junko Yamamoto-Kishikawa; Yuya Kinoshita; Yusuke Morimoto; Kazuhito Imamura; Mahboob Morshed; Ken Kono; Toshinari Itoh; Ken-ichi Nishijima; Shinji Iijima
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

3.  EOS lentiviral vector selection system for human induced pluripotent stem cells.

Authors:  Akitsu Hotta; Aaron Y L Cheung; Natalie Farra; Kamal Garcha; Wing Y Chang; Peter Pasceri; William L Stanford; James Ellis
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

4.  Effects of B-cell lymphoma 2 gene transfer to myoblast cells on skeletal muscle tissue formation using magnetic force-based tissue engineering.

Authors:  Masanori Sato; Akira Ito; Hirokazu Akiyama; Yoshinori Kawabe; Masamichi Kamihira
Journal:  Tissue Eng Part A       Date:  2012-11-21       Impact factor: 3.845

5.  Oral immunotherapy for pollen allergy using T-cell epitope-containing egg white derived from genetically manipulated chickens.

Authors:  Yoshinori Kawabe; Yuuki Hayashida; Kensaku Numata; Shota Harada; Yoshifumi Hayashida; Akira Ito; Masamichi Kamihira
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

6.  In vitro drug testing based on contractile activity of C2C12 cells in an epigenetic drug model.

Authors:  Kazushi Ikeda; Akira Ito; Ryusuke Imada; Masanori Sato; Yoshinori Kawabe; Masamichi Kamihira
Journal:  Sci Rep       Date:  2017-03-16       Impact factor: 4.379

7.  Improved contractile force generation of tissue-engineered skeletal muscle constructs by IGF-I and Bcl-2 gene transfer with electrical pulse stimulation.

Authors:  Kazushi Ikeda; Akira Ito; Masanori Sato; Yoshinori Kawabe; Masamichi Kamihira
Journal:  Regen Ther       Date:  2016-03-16       Impact factor: 3.419

Review 8.  Alpharetroviral vectors: from a cancer-causing agent to a useful tool for human gene therapy.

Authors:  Julia D Suerth; Verena Labenski; Axel Schambach
Journal:  Viruses       Date:  2014-12-05       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.